Home/Filings/4/0001179110-15-001281
4//SEC Filing

CymaBay Therapeutics, Inc. 4

Accession 0001179110-15-001281

CIK 0001042074operating

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 8:07 PM ET

Size

5.5 KB

Accession

0001179110-15-001281

Insider Transaction Report

Form 4
Period: 2015-01-07
Boudes Pol F
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2015-01-07+75,00075,000 total
    Exercise: $10.00Exp: 2025-01-07Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]The option vests with respect to one-quarter of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares monthly thereafter over the next three years.

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001042074

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 8:07 PM ET
Size
5.5 KB